Novartis AG - Other Non Cash Items

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Non-Cash-Items" stands at -1.83 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Novartis AG's third quarter result of -0.593 Billion USD for the item "Other Non Cash Items" represents a decrease of -452.98 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of -0.593 Billion USD for the item "Other Non Cash Items" represents a decrease of -65.18 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of -1.83 Billion USD for the item "Other Non Cash Items" represents a decrease of -14.64 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.34 Billion United States Dollars compared to the value the year prior.
The 1 year change is -1.34 Billion United States Dollars.
The 3 year change is 13.75 Billion United States Dollars.
The 5 year change is 0.122 Billion United States Dollars.
The 10 year change is -2.61 Billion United States Dollars.

The Serie's long term average value is -2.02 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.188 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2021, to it's latest available value, on 09/30/2025, is +14.97 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2012, to it's latest available value, on 09/30/2025, is -5.73 Billion.